Sanofi pays $300m upfront to expand deal with Translate Bio
admin 23rd June 2020 Uncategorised 0The firms are working on the development of mRNA vaccines More: Sanofi pays 0m upfront to expand deal with Translate Bio Source: News
read more
The firms are working on the development of mRNA vaccines More: Sanofi pays 0m upfront to expand deal with Translate Bio Source: News
read moreBoehringer’s stake in the firm equates to around 16.4% More: Boehringer to sell stake in Hikma Source: News
read moreOver 14,000 GP staff, other essential key workers and university staff and their households will participate in the first phase of the trial More: New coronavirus saliva test to be trialled in Southampton Source: News
read moreThe scientific opinion has been extended for one year while the drug is under regulatory review More: MHRA extends access to Santhera's DMD drug via the EAMS Source: News
read moreThe firm is targeting an earlier stage in the treatment pathway for COVID-19 More: Gilead to start testing an inhaled form of remdesivir Source: News
read moreMylan, looking to capitalize on Biogen’s Tecfidera patent loss, faces fork in the road on generic launch kblankenship Mon, 06/22/2020 – 11:17 More: Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
read more© 1994 - 2026 B.M. Pharmaceuticals